# Efficacy of Artesunate-amodiaquine (AS-AQ) in Children With Malaria and Severe Acute Malnutrition, Madaoua, Niger 2010

> **NCT01204411** · PHASE4 · WITHDRAWN · sponsor: **Epicentre**

## Conditions studied

- Malaria, Falciparum
- Malnutrition
- Child

## Interventions

- **DRUG:** Artesunate-amodiaquine fixed-dose combination

## Key facts

- **NCT ID:** NCT01204411
- **Lead sponsor:** Epicentre
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** The ethics committee did not approve the pharmacokinetic part of the study.
- **Last updated:** 2012-11-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01204411

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01204411, "Efficacy of Artesunate-amodiaquine (AS-AQ) in Children With Malaria and Severe Acute Malnutrition, Madaoua, Niger 2010". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT01204411. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*